NAUT
Price
$1.54
Change
-$0.06 (-3.75%)
Updated
Feb 21 closing price
Capitalization
193.37M
5 days until earnings call
PRTA
Price
$15.56
Change
+$0.31 (+2.03%)
Updated
Feb 21 closing price
Capitalization
836.99M
80 days until earnings call
Ad is loading...

NAUT vs PRTA

Header iconNAUT vs PRTA Comparison
Open Charts NAUT vs PRTABanner chart's image
Nautilus Biotechnolgy
Price$1.54
Change-$0.06 (-3.75%)
Volume$79.83K
Capitalization193.37M
Prothena
Price$15.56
Change+$0.31 (+2.03%)
Volume$732.65K
Capitalization836.99M
NAUT vs PRTA Comparison Chart
Loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAUT vs. PRTA commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAUT is a Hold and PRTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (NAUT: $1.60 vs. PRTA: $15.25)
Brand notoriety: NAUT and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAUT: 59% vs. PRTA: 69%
Market capitalization -- NAUT: $193.37M vs. PRTA: $836.99M
NAUT [@Biotechnology] is valued at $193.37M. PRTA’s [@Biotechnology] market capitalization is $836.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAUT’s FA Score shows that 1 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • NAUT’s FA Score: 1 green, 4 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, NAUT is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAUT’s TA Score shows that 2 TA indicator(s) are bullish while PRTA’s TA Score has 4 bullish TA indicator(s).

  • NAUT’s TA Score: 2 bullish, 5 bearish.
  • PRTA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRTA is a better buy in the short-term than NAUT.

Price Growth

NAUT (@Biotechnology) experienced а -6.98% price change this week, while PRTA (@Biotechnology) price change was +9.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

NAUT is expected to report earnings on May 06, 2025.

PRTA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($837M) has a higher market cap than NAUT($193M). PRTA YTD gains are higher at: 10.108 vs. NAUT (-4.762). NAUT has higher annual earnings (EBITDA): -75.11M vs. PRTA (-167.23M). PRTA has more cash in the bank: 519M vs. NAUT (141M). PRTA has less debt than NAUT: PRTA (11.5M) vs NAUT (31.6M). PRTA has higher revenues than NAUT: PRTA (133M) vs NAUT (0).
NAUTPRTANAUT / PRTA
Capitalization193M837M23%
EBITDA-75.11M-167.23M45%
Gain YTD-4.76210.108-47%
P/E RatioN/AN/A-
Revenue0133M-
Total Cash141M519M27%
Total Debt31.6M11.5M275%
FUNDAMENTALS RATINGS
NAUT vs PRTA: Fundamental Ratings
NAUT
PRTA
OUTLOOK RATING
1..100
319
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
8962
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
41n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (19) in the null industry is somewhat better than the same rating for PRTA (62) in the Biotechnology industry. This means that NAUT’s stock grew somewhat faster than PRTA’s over the last 12 months.

PRTA's Profit vs Risk Rating (94) in the Biotechnology industry is in the same range as NAUT (100) in the null industry. This means that PRTA’s stock grew similarly to NAUT’s over the last 12 months.

PRTA's SMR Rating (94) in the Biotechnology industry is in the same range as NAUT (95) in the null industry. This means that PRTA’s stock grew similarly to NAUT’s over the last 12 months.

PRTA's Price Growth Rating (62) in the Biotechnology industry is in the same range as NAUT (89) in the null industry. This means that PRTA’s stock grew similarly to NAUT’s over the last 12 months.

PRTA's P/E Growth Rating (94) in the Biotechnology industry is in the same range as NAUT (100) in the null industry. This means that PRTA’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAUTPRTA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLCKX13.77N/A
N/A
Federated Hermes Kaufmann Large Cap R
GABEX6.38N/A
N/A
Gabelli Equity Income AAA
EPVIX11.34N/A
N/A
EuroPac International Value I
HQIVX21.42N/A
N/A
Hartford Equity Income R6
UIVNX12.35N/A
N/A
MFS Intrinsic Value R2

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with AURA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-4.19%
AURA - NAUT
43%
Loosely correlated
-0.26%
AXON - NAUT
42%
Loosely correlated
-8.70%
GBIO - NAUT
42%
Loosely correlated
-6.35%
FHTX - NAUT
41%
Loosely correlated
-8.35%
FATE - NAUT
41%
Loosely correlated
-9.65%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+1.80%
DNLI - PRTA
50%
Loosely correlated
-2.88%
CLDX - PRTA
42%
Loosely correlated
-2.00%
BEAM - PRTA
42%
Loosely correlated
-2.79%
NTLA - PRTA
41%
Loosely correlated
-0.24%
NAUT - PRTA
41%
Loosely correlated
-4.19%
More